Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents - Wikidata - wikimedia - TriplyDB

Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents

Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents

http://www.wikidata.org/entity/Q36595586

about

Venezuelan equine encephalitis virus infection of mosquito cells requires acidification as well as mosquito homologs of the endocytic proteins Rab5 and Rab7 Lipoplexes and tumours. A review.In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein.Separable mechanisms of attachment and cell uptake during retrovirus infection.Efficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectors Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirus Quantitative analysis of PPT1 interactome in human neuroblastoma cells.Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells.Design of hybrid lipid/retroviral-like particle gene delivery vectors.Association of murine leukemia virus pol with virions, independent of Gag-Pol expression Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.HIV virions sense plasma membrane heterogeneity for cell entry.Assembly of hepatitis B virus envelope proteins onto a lentivirus pseudotype that infects primary human hepatocytes.

P2860

Q27486420-D295968E-E855-4A7A-AF97-CD76AF882315 Q33723073-E20F6999-DBD6-4AC0-BB20-6F463DAED46C Q33783325-2C26909D-73C8-4C61-AC03-E89CEFC17C17 Q33785847-385D305A-8709-4413-9375-E2A7C0523FAC Q33787363-D018023B-AC51-4F02-BBBB-F232F843A891 Q34216718-D0F44AAC-F59F-49C8-A251-3D40D458A0BA Q35239213-3933242C-99B8-4E83-A1F9-E9F4C8598201 Q35877183-F5DAFA73-875D-4950-A309-CFB1BF806F38 Q36014113-CB944103-914F-45E5-9604-EC44000689D3 Q36823864-B2BAEA93-0894-4949-ADE4-5111A1768328 Q39596700-65A4A16D-788D-4768-9F99-8A8D6C40B911 Q39756385-2F740B5D-7C93-4DEF-ADC4-770B34FD0101 Q40092770-D7B4EE18-D820-4F15-83B1-02BF46361A12 Q40099387-E27AFFB2-A5AE-4D98-B3A9-13442DD51B47

P2860

Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents

http://www.wikidata.org/entity/Q36595586

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Noninfectious virus-like parti ...... esence of lipofection reagents

@ast

Noninfectious virus-like parti ...... esence of lipofection reagents

@en

type

label

Noninfectious virus-like parti ...... esence of lipofection reagents

@ast

Noninfectious virus-like parti ...... esence of lipofection reagents

@en

prefLabel

Noninfectious virus-like parti ...... esence of lipofection reagents

@ast

Noninfectious virus-like parti ...... esence of lipofection reagents

@en

P1433

Q36595586-041DB882-A4E9-4E12-AD57-D1488AE976C2

P1476

Q36595586-B363731F-EEDA-4A9C-A654-DD791718EC7A

P2093

Q36595586-2B1F9500-BADC-46DA-B71A-3B5E88031EE4

Q36595586-A5CF3B4D-22AA-40F5-ACF6-23758773089C

Q36595586-D5385B48-FE82-4F4E-B493-BDE43B256148

Q36595586-DBB9BD00-2867-4939-B0CC-85B2BA571B5C

P2860

Q36595586-00E26E5B-880F-44C5-8658-E219BA2C0D5E

Q36595586-1354A63B-4A8C-4F38-AB52-A149C42078E1

Q36595586-1555E2E4-FEC2-40D9-90AB-A76B8D0F60E4

Q36595586-19207968-AFE4-4D8D-8854-44459CE90C7B

Q36595586-1D774AE9-049B-4B73-999A-CA3E7FE09DC0

Q36595586-2648210C-094B-4ED8-818B-FDD3CDC4B5B6

Q36595586-2ACF13B6-08B9-44CE-AEB0-FB34B03E45ED

Q36595586-33E82B32-5C93-4D91-A33F-A4CD7237AE78

Q36595586-355DBA22-FAF7-418B-ABE9-58BA2E2AB71B

Q36595586-46FFF682-E0B6-47E1-A4F0-E57E506D3C77

P304

Q36595586-565087C6-54BA-4106-B5BA-A6A59D23307E

P31

Q36595586-A831A8F7-FABE-4CB7-8EE4-1AAC76CAF3C5

P356

Q36595586-B11E7E94-AF2C-46F6-A391-B4B3552BE4FD

P407

Q36595586-AAA806B9-8F37-491B-B254-B951947B5680

P433

Q36595586-4EF979AE-254F-430E-83FC-18709463F8F1

P478

Q36595586-3F7AC26C-B944-40A6-8647-FC1A2F76BFFB

P577

Q36595586-1F763E53-D9EB-4B6A-BEAD-EBEE9ED5A6B6

P5875

Q36595586-FC1535FA-4FF5-4236-BFF2-D91D9F45FC9B

P698

Q36595586-B6DF9185-B4C4-4DB9-B528-290E1BB51C28

P921

Q36595586-0D66C1E3-2554-40D1-8326-3721E2EC1F7F

P932

Q36595586-F78B5666-1430-4CCE-AB27-80EA399D134E

P356

PNAS.94.20.10803

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Noninfectious virus-like parti ...... esence of lipofection reagents

@en

P2093

A Miyanohara

http://www.w3.org/2001/XMLSchema#string

F Murai

http://www.w3.org/2001/XMLSchema#string

S Sharma

http://www.w3.org/2001/XMLSchema#string

T Friedmann

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release

An assembly domain of the Rous sarcoma virus Gag protein required late in budding

Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus

Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus

Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation.

Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.

Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.

A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes.

Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.

Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents

P304

10803-10808

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.20.10803

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P577

1997-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13848708

http://www.w3.org/2001/XMLSchema#string

P698

9380714

http://www.w3.org/2001/XMLSchema#string

P921

P932

23491

http://www.w3.org/2001/XMLSchema#string